Basic Materials / Specialty ChemicalsIstanbul
$34.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-50.4M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
68/100
B
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.6B
P/E
94.4x
↑EV/EBITDA
7.6x
↓ROE
1.5%
↑Gross Margin
33.9%
↑Debt/Equity
0.03
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+21.1%
FCF CAGR
—
FCF margin
-4.7%
FCF / Net income
-3.08x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.07B · net income $16.4M · FCF $-50.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.07B | $1.07B | $942.5M | $848.7M | $601.4M |
| Net Income | $16.4M | $16.4M | $8.7M | $107.9M | $-17.4M |
| EBITDA | $190.8M | $190.8M | $77.8M | $166.2M | $50.8M |
| EPS | 0.35 | 0.35 | 0.19 | 2.31 | -0.38 |
| Gross Margin | 33.9% | 33.9% | 19.1% | 40.0% | 34.4% |
| Operating Margin | 24.9% | 24.9% | 5.5% | 30.4% | 27.1% |
| Net Margin | 1.5% | 1.5% | 0.9% | 12.7% | -2.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.03 | 0.03 | 0.09 | 0.07 | 0.10 |
| Current Ratio | 3.90 | 3.90 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-50.4M | $-50.4M | $-125.9M | $17.5M | $37.1M |
| Returns | |||||
| ROE | 1.5% | 1.5% | 0.8% | 13.4% | -3.6% |
| Valuation | |||||
| P/E | 94.44 | 94.44 | 153.79 | 8.48 | — |
| EV/EBITDA | 7.59 | 7.59 | — | 5.00 | 7.73 |
| P/B | 1.48 | 1.48 | — | 1.14 | 0.84 |
| Growth & Yield | |||||
| Revenue Growth | 13.2% | 13.2% | 11.1% | 41.1% | — |
| EPS Growth | 84.2% | 84.2% | -91.8% | 716.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
105.0%
EPS terminal req.
$3.02
Spread vs growth
-20.8%
5Y implied EPS CAGR
59.8%
EPS terminal req.
$3.65
Spread vs growth
24.4%
10Y implied EPS CAGR
32.6%
EPS terminal req.
$5.88
Spread vs growth
51.6%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+67.0%
Start / end P/E
107.5x → 97.4x
EPS bridge
0.19 → 0.35
Residual
-7.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.